1h Free Analyst Time
The global antiemetic drug market is forecasted to grow by USD 1.91 billion during 2025-2030, accelerating at a CAGR of 6.4% during the forecast period. The report on the global antiemetic drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cancer and demand for chemotherapy induced nausea, advancements in formulation technologies and delivery systems, expansion into non-oncology indications for motion sickness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global antiemetic drug market is segmented as below:
By Drug Class
- 5-HT 3 receptor antagonist
- Dopamine antagonist
- NK 1 receptor antagonist
- Cannabinoid receptor antagonist
- Others
By Application
- Chemotherapy
- Surgery
- Gastroenteritis
- Others
By Route Of Administration
- Injectable
- Oral
- Transdermal
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (RoW)
The report on the global antiemetic drug market covers the following areas:
- Global antiemetic drug market sizing
- Global antiemetic drug market forecast
- Global antiemetic drug market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Antiemetic Drug Market 2020 - 2024
- Historic Market Size - Data Table on Global Antiemetic Drug Market 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Antiemetic Drug Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Drug Class
8.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
- Chart on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
- Chart on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
- Chart on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Application
9.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
- Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
- Chart on Surgery - Market size and forecast 2025-2030 ($ million)
- Data Table on Surgery - Market size and forecast 2025-2030 ($ million)
- Chart on Surgery - Year-over-year growth 2025-2030 (%)
- Data Table on Surgery - Year-over-year growth 2025-2030 (%)
- Chart on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
- Data Table on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
- Chart on Gastroenteritis - Year-over-year growth 2025-2030 (%)
- Data Table on Gastroenteritis - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
- Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
- Chart on Transdermal - Year-over-year growth 2025-2030 (%)
- Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising prevalence of cancer and demand for chemotherapy induced nausea
- Advancements in formulation technologies and delivery systems
- Expansion into non-oncology indications for motion sickness
- Adverse effects and safety concerns associated with antiemetic drugs
- Intense generic competition and price erosion
- Management of breakthrough and refractory nausea
- Impact of drivers and challenges in 2025 and 2030
- Increasing adoption of ready to use and long-acting injectable formulations
- Strategic partnerships and acquisitions to expand portfolios
- Regulatory encouragement for multi mechanism
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
- Helsinn Healthcare SA - Overview
- Helsinn Healthcare SA - Product / Service
- Helsinn Healthcare SA - Key offerings
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Sandoz Group AG - Overview
- Sandoz Group AG - Product / Service
- Sandoz Group AG - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Product / Service
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Product / Service
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Antiemetic Drug Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 39: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Drug Class
Exhibit 41: Data Table on Comparison by Drug Class
Exhibit 42: Chart on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Drug Class ($ million)
Exhibit 63: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 64: Chart on Application - Market share 2025-2030 (%)
Exhibit 65: Data Table on Application - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Application
Exhibit 67: Data Table on Comparison by Application
Exhibit 68: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Surgery - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Surgery - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Gastroenteritis - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Gastroenteritis - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 84: Market opportunity by Application ($ million)
Exhibit 85: Data Table on Market opportunity by Application ($ million)
Exhibit 86: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 87: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 88: Chart on Comparison by Route of Administration
Exhibit 89: Data Table on Comparison by Route of Administration
Exhibit 90: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 102: Market opportunity by Route of Administration ($ million)
Exhibit 103: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 105: Chart on Market share by geography 2025-2030 (%)
Exhibit 106: Data Table on Market share by geography 2025-2030 (%)
Exhibit 107: Chart on Geographic comparison
Exhibit 108: Data Table on Geographic comparison
Exhibit 109: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Regional Comparison - North America
Exhibit 114: Data Table on Regional Comparison - North America
Exhibit 115: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Regional Comparison - Europe
Exhibit 132: Data Table on Regional Comparison - Europe
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 200: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 225: Market opportunity by geography ($ million)
Exhibit 226: Data Tables on Market opportunity by geography ($ million)
Exhibit 227: Impact of drivers and challenges in 2025 and 2030
Exhibit 228: Overview on criticality of inputs and factors of differentiation
Exhibit 229: Overview on factors of disruption
Exhibit 230: Impact of key risks on business
Exhibit 231: Companies covered
Exhibit 232: Company ranking index
Exhibit 233: Matrix on companies position and classification
Exhibit 234: B.Braun SE - Overview
Exhibit 235: B.Braun SE - Product / Service
Exhibit 236: B.Braun SE - Key news
Exhibit 237: B.Braun SE - Key offerings
Exhibit 238: SWOT
Exhibit 239: Baxter International Inc. - Overview
Exhibit 240: Baxter International Inc. - Business segments
Exhibit 241: Baxter International Inc. - Key news
Exhibit 242: Baxter International Inc. - Key offerings
Exhibit 243: Baxter International Inc. - Segment focus
Exhibit 244: SWOT
Exhibit 245: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 246: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 247: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 250: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 251: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 252: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 253: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: F. Hoffmann La Roche Ltd. - Overview
Exhibit 256: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 257: F. Hoffmann La Roche Ltd. - Key news
Exhibit 258: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 259: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 260: SWOT
Exhibit 261: Fresenius Kabi AG - Overview
Exhibit 262: Fresenius Kabi AG - Product / Service
Exhibit 263: Fresenius Kabi AG - Key offerings
Exhibit 264: SWOT
Exhibit 265: Helsinn Healthcare SA - Overview
Exhibit 266: Helsinn Healthcare SA - Product / Service
Exhibit 267: Helsinn Healthcare SA - Key offerings
Exhibit 268: SWOT
Exhibit 269: Merck and Co. Inc. - Overview
Exhibit 270: Merck and Co. Inc. - Business segments
Exhibit 271: Merck and Co. Inc. - Key news
Exhibit 272: Merck and Co. Inc. - Key offerings
Exhibit 273: Merck and Co. Inc. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Novartis AG - Overview
Exhibit 276: Novartis AG - Business segments
Exhibit 277: Novartis AG - Key news
Exhibit 278: Novartis AG - Key offerings
Exhibit 279: Novartis AG - Segment focus
Exhibit 280: SWOT
Exhibit 281: Sandoz Group AG - Overview
Exhibit 282: Sandoz Group AG - Product / Service
Exhibit 283: Sandoz Group AG - Key offerings
Exhibit 284: SWOT
Exhibit 285: Sanofi SA - Overview
Exhibit 286: Sanofi SA - Business segments
Exhibit 287: Sanofi SA - Key news
Exhibit 288: Sanofi SA - Key offerings
Exhibit 289: Sanofi SA - Segment focus
Exhibit 290: SWOT
Exhibit 291: Sun Pharmaceutical Industries - Overview
Exhibit 292: Sun Pharmaceutical Industries - Product / Service
Exhibit 293: Sun Pharmaceutical Industries - Key news
Exhibit 294: Sun Pharmaceutical Industries - Key offerings
Exhibit 295: SWOT
Exhibit 296: Takeda Pharmaceutical Ltd. - Overview
Exhibit 297: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 298: Takeda Pharmaceutical Ltd. - Key news
Exhibit 299: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 300: SWOT
Exhibit 301: Teva Pharmaceutical Ltd. - Overview
Exhibit 302: Teva Pharmaceutical Ltd. - Business segments
Exhibit 303: Teva Pharmaceutical Ltd. - Key news
Exhibit 304: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 305: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 306: SWOT
Exhibit 307: Viatris Inc. - Overview
Exhibit 308: Viatris Inc. - Business segments
Exhibit 309: Viatris Inc. - Key news
Exhibit 310: Viatris Inc. - Key offerings
Exhibit 311: Viatris Inc. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Inclusions checklist
Exhibit 314: Exclusions checklist
Exhibit 315: Currency conversion rates for US$
Exhibit 316: Research methodology
Exhibit 317: Information sources
Exhibit 318: Data validation
Exhibit 319: Validation techniques employed for market sizing
Exhibit 320: Data synthesis
Exhibit 321: 360 degree market analysis
Exhibit 322: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Antiemetic Drug Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 39: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Drug Class
Exhibit 41: Data Table on Comparison by Drug Class
Exhibit 42: Chart on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Dopamine antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Dopamine antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Drug Class ($ million)
Exhibit 63: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 64: Chart on Application - Market share 2025-2030 (%)
Exhibit 65: Data Table on Application - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Application
Exhibit 67: Data Table on Comparison by Application
Exhibit 68: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Surgery - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Surgery - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Gastroenteritis - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Gastroenteritis - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Gastroenteritis - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 84: Market opportunity by Application ($ million)
Exhibit 85: Data Table on Market opportunity by Application ($ million)
Exhibit 86: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 87: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 88: Chart on Comparison by Route of Administration
Exhibit 89: Data Table on Comparison by Route of Administration
Exhibit 90: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 102: Market opportunity by Route of Administration ($ million)
Exhibit 103: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 105: Chart on Market share by geography 2025-2030 (%)
Exhibit 106: Data Table on Market share by geography 2025-2030 (%)
Exhibit 107: Chart on Geographic comparison
Exhibit 108: Data Table on Geographic comparison
Exhibit 109: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Regional Comparison - North America
Exhibit 114: Data Table on Regional Comparison - North America
Exhibit 115: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Regional Comparison - Europe
Exhibit 132: Data Table on Regional Comparison - Europe
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 200: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 225: Market opportunity by geography ($ million)
Exhibit 226: Data Tables on Market opportunity by geography ($ million)
Exhibit 227: Impact of drivers and challenges in 2025 and 2030
Exhibit 228: Overview on criticality of inputs and factors of differentiation
Exhibit 229: Overview on factors of disruption
Exhibit 230: Impact of key risks on business
Exhibit 231: Companies covered
Exhibit 232: Company ranking index
Exhibit 233: Matrix on companies position and classification
Exhibit 234: B.Braun SE - Overview
Exhibit 235: B.Braun SE - Product / Service
Exhibit 236: B.Braun SE - Key news
Exhibit 237: B.Braun SE - Key offerings
Exhibit 238: SWOT
Exhibit 239: Baxter International Inc. - Overview
Exhibit 240: Baxter International Inc. - Business segments
Exhibit 241: Baxter International Inc. - Key news
Exhibit 242: Baxter International Inc. - Key offerings
Exhibit 243: Baxter International Inc. - Segment focus
Exhibit 244: SWOT
Exhibit 245: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 246: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 247: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 250: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 251: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 252: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 253: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: F. Hoffmann La Roche Ltd. - Overview
Exhibit 256: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 257: F. Hoffmann La Roche Ltd. - Key news
Exhibit 258: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 259: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 260: SWOT
Exhibit 261: Fresenius Kabi AG - Overview
Exhibit 262: Fresenius Kabi AG - Product / Service
Exhibit 263: Fresenius Kabi AG - Key offerings
Exhibit 264: SWOT
Exhibit 265: Helsinn Healthcare SA - Overview
Exhibit 266: Helsinn Healthcare SA - Product / Service
Exhibit 267: Helsinn Healthcare SA - Key offerings
Exhibit 268: SWOT
Exhibit 269: Merck and Co. Inc. - Overview
Exhibit 270: Merck and Co. Inc. - Business segments
Exhibit 271: Merck and Co. Inc. - Key news
Exhibit 272: Merck and Co. Inc. - Key offerings
Exhibit 273: Merck and Co. Inc. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Novartis AG - Overview
Exhibit 276: Novartis AG - Business segments
Exhibit 277: Novartis AG - Key news
Exhibit 278: Novartis AG - Key offerings
Exhibit 279: Novartis AG - Segment focus
Exhibit 280: SWOT
Exhibit 281: Sandoz Group AG - Overview
Exhibit 282: Sandoz Group AG - Product / Service
Exhibit 283: Sandoz Group AG - Key offerings
Exhibit 284: SWOT
Exhibit 285: Sanofi SA - Overview
Exhibit 286: Sanofi SA - Business segments
Exhibit 287: Sanofi SA - Key news
Exhibit 288: Sanofi SA - Key offerings
Exhibit 289: Sanofi SA - Segment focus
Exhibit 290: SWOT
Exhibit 291: Sun Pharmaceutical Industries - Overview
Exhibit 292: Sun Pharmaceutical Industries - Product / Service
Exhibit 293: Sun Pharmaceutical Industries - Key news
Exhibit 294: Sun Pharmaceutical Industries - Key offerings
Exhibit 295: SWOT
Exhibit 296: Takeda Pharmaceutical Ltd. - Overview
Exhibit 297: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 298: Takeda Pharmaceutical Ltd. - Key news
Exhibit 299: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 300: SWOT
Exhibit 301: Teva Pharmaceutical Ltd. - Overview
Exhibit 302: Teva Pharmaceutical Ltd. - Business segments
Exhibit 303: Teva Pharmaceutical Ltd. - Key news
Exhibit 304: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 305: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 306: SWOT
Exhibit 307: Viatris Inc. - Overview
Exhibit 308: Viatris Inc. - Business segments
Exhibit 309: Viatris Inc. - Key news
Exhibit 310: Viatris Inc. - Key offerings
Exhibit 311: Viatris Inc. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Inclusions checklist
Exhibit 314: Exclusions checklist
Exhibit 315: Currency conversion rates for US$
Exhibit 316: Research methodology
Exhibit 317: Information sources
Exhibit 318: Data validation
Exhibit 319: Validation techniques employed for market sizing
Exhibit 320: Data synthesis
Exhibit 321: 360 degree market analysis
Exhibit 322: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global antiemetic drug market: Acacia Pharma Group Plc, Accord Healthcare Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Helsinn Healthcare SA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sandoz Group AG, Sanofi SA, Sun Pharmaceutical Industries, Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing adoption of ready to use and long-acting injectable formulations."
According to the report, one of the major drivers for this market is the rising prevalence of cancer and demand for chemotherapy induced nausea.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acacia Pharma Group Plc
- Accord Healthcare Ltd.
- Astellas Pharma Inc.
- B.Braun SE
- Baxter International Inc.
- Cadila Pharmaceuticals Ltd.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Fresenius Kabi AG
- GlaxoSmithKline Plc
- Helsinn Healthcare SA
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sandoz Group AG
- Sanofi SA
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd.
- Viatris Inc.
